A clinical study analyzed that in both CD4+ and CD8+ TRM cells, the proportion of CD103+ TRM cells in IBD is reduced during the inflammation phase, indicating that CD103+ TRM cells may be involved in maintaining mucosal homeostasis and regulating the immune response (80, 81). The gene discussed is CD4; the disease is inflammatory bowel disease.